Allox Tablet
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Samnam Pharmaceutical Co., Ltd.
MFDS item code 201503498 · Notified 2015.05.29
This product's status changed to Expired on 2025.05.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (ulcers, gastritis, gastroesophageal reflux disease, etc.); prevention of Mendelson's syndrome
This medicine is used for various gastrointestinal disorders including gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective for the prevention of Mendelson's syndrome before anesthesia and for the treatment of ulcers after surgery. This medicine is utilized for the treatment of gastric and duodenal ulcers caused by the use of nonsteroidal anti-inflammatory drugs (NSAIDs). By regulating gastric acid secretion, it helps alleviate symptoms and promote healing. These properties make it useful for improving symptoms associated with gastrointestinal disorders.
Usually, take 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or for combination therapy to prevent gastric or duodenal ulcers during long-term NSAID treatment. Conditions caused by NSAID treatment usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. The dose may be increased to 4 tablets four times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets three times daily; the dose may be increased as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Give 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to give 2 tablets on the evening before surgery.
This medicine should not be used in patients with severely impaired kidney function or those undergoing dialysis. Individuals who have had allergic reactions to this medication should not take it. Patients with the rare condition of acute porphyria should avoid this medication as it may exacerbate symptoms. It should not be administered to pregnant women or those who may become pregnant, nor to premature infants or newborns. Patients on potassium-restricted diets should also refrain from using this medication. Patients with poor liver function or a history of drug allergies should use this medication with caution. Elderly patients or those with kidney issues should also be administered this drug cautiously. Patients taking nonsteroidal anti-inflammatory drugs should have periodic monitoring. As this medication may obscure symptoms of gastric cancer, patients with gastric ulcers or newly developed dyspepsia who are middle-aged or older should be evaluated for malignancy before treatment. Patients with gastric and duodenal ulcers infected with Helicobacter pylori require bacterial eradication treatment. Extreme caution is required for critically ill patients in intensive care, patients with hypophosphatemia, or those with swallowing difficulties. Rarely, allergic reactions or shock may occur when taking this medication; if any unusual symptoms appear, discontinue immediately and consult a healthcare professional. Blood cell counts may decrease or liver function may become abnormal; therefore, if symptoms occur, testing should be conducted, and the use of the drug should be stopped. Be vigilant for cardiovascular irregularities, gastrointestinal symptoms, dizziness or drowsiness, and mental confusion. Symptoms such as muscle pain or skin rash have also been reported, and should be communicated to a healthcare professional. Long-term use is not recommended, and the minimal effective dose should be used while monitoring treatment outcomes. Elderly patients or those with chronic diseases may be at increased risk of pneumonia, necessitating careful monitoring. If dizziness or drowsiness occurs during treatment, avoid operating vehicles or hazardous machinery. There may be interactions with other medications, so it is essential to inform healthcare providers about any concurrent medications. In particular, adjustments in dosing intervals or monitoring may be needed for some antibiotics or anticoagulants. It is safe to refrain from this medication for women who are pregnant or breastfeeding. Safety in children has not been thoroughly established, so it is advisable to avoid use in pediatrics. Overdose may require emergency measures such as vomiting or gastric lavage, so proceed with caution. This medication can reduce gastric acid secretion, potentially promoting bacterial growth in the gastrointestinal tract, necessitating possible ophthalmologic examination with long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that is well-ventilated and kept at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the efficacy and prevents degradation of the medication.
This medicine is a round white film-coated tablet.
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Samnam Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.